Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Azadine Injection:
Azadine Injection is utilized in the treatment of certain types of blood cancer, specifically for adult patients with all subtypes of Myelodysplastic Syndrome (MDS). Additionally, it may be prescribed for other conditions as determined by your doctor.
Administered as an infusion under the clinical supervision of a physician, the dosage and frequency will be determined by your doctor based on your condition, which may vary over time. It is crucial to adhere to your doctor's advice precisely to avoid potential side effects. While it may take weeks or months to observe the benefits of Azadine Injection, it is important not to discontinue the treatment unless advised by your doctor.
Uses of Azadine Injection:
Blood cancer
Treatment of Myelodysplastic Syndrome (MDS)
Benefits of Azadine Injection:
In Blood cancer:
Blood cancer, known as leukemia, affects the blood-forming tissues, reducing the body's ability to fight infections. Azadine Injection works by halting the growth of cancer cells and preventing their proliferation. It is a potent and highly toxic medication, and it is essential to discuss the risks and benefits with your doctor. It is recommended to avoid alcohol consumption during treatment and stay hydrated by drinking plenty of water.
In Treatment of Myelodysplastic Syndrome (MDS):
Azadine Injection is used to treat Myelodysplastic Syndrome, a group of conditions where the bone marrow produces abnormal blood cells and fails to produce enough healthy blood cells. Similar to its action in blood cancer, Azadine Injection inhibits the growth of cancer cells and prevents their proliferation. It is essential to discuss the risks and benefits with your doctor due to its potent and highly toxic nature. It is recommended to avoid alcohol consumption during treatment and stay hydrated by drinking plenty of water.
Mechanism of action of Azadine Injection:
Azadine Injection is an anticancer medicine that works by slowing down the growth of genetic material (DNA and RNA) of cancer cells in leukemia. This action leads to the destruction of cancer cells and promotes normal growth and development of young blood cells in the bone marrow.